87 related articles for article (PubMed ID: 2982333)
1. [Enhanced cytotoxic effect of Adriamycin and vincristine against PC-6 (human lung cancer cell line) and Hattori (human breast cancer cell line)].
Terashima M; Inoue K; Mukaiyama T; Mitsui I; Ogawa M
Gan To Kagaku Ryoho; 1985 Feb; 12(2):343-7. PubMed ID: 2982333
[TBL] [Abstract][Full Text] [Related]
2. [A randomized phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin and adriamycin in combination with vincristine and ACNU in small cell lung cancer--THP-ADM, VCR, ACNU vs ADM, VCR, ACNU].
Hino M; Kobayashi K; Kurane S; Nukariya N; Yamano Y; Hasegawa K; Tsuboi E; Niitani H
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3143-8. PubMed ID: 2551250
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of small cell lung cancer].
Komiya T; Takada M
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
[TBL] [Abstract][Full Text] [Related]
4. [Flow cytometric study of enhanced effect of anti-cancer drugs induced by nicardipine hydrochloride].
Nomura K; Watanabe T; Nakamura O; Shibui S
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2252-60. PubMed ID: 6593005
[TBL] [Abstract][Full Text] [Related]
5. [Randomized systemic chemotherapy using two or three drug combination for small cell lung cancer (SCLC)].
Eguchi K; Shimizu E; Shinkai T; Tominaga K; Saijo N; Shimabukuro Z; Shibuya M; Niitani H
Gan No Rinsho; 1984 Feb; 30(2):115-21. PubMed ID: 6323783
[TBL] [Abstract][Full Text] [Related]
6. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
7. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
8. Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).
Timothy AR; Calman FM; Bateman NT; Farebrother M; Slevin ML; Bellamy D; Rubens RD; Costello J
Semin Oncol; 1985 Mar; 12(1 Suppl 2):45-7. PubMed ID: 2983435
[TBL] [Abstract][Full Text] [Related]
9. [A randomized trial of 3-drug combination chemotherapy in small cell lung cancer--CPA/ACNU/VCR vs ADR/ACNU/VCR].
Furuse K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1844-9. PubMed ID: 2994577
[TBL] [Abstract][Full Text] [Related]
10. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
[TBL] [Abstract][Full Text] [Related]
11. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
Perevodchikova NI; Bychkov MB; Ausekar BV
Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer.
Gandhi L; Harding MW; Neubauer M; Langer CJ; Moore M; Ross HJ; Johnson BE; Lynch TJ
Cancer; 2007 Mar; 109(5):924-32. PubMed ID: 17285598
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of treatment of recurrent small-cell lung cancer.
Hosp Med; 1999 Mar; 60(3):220. PubMed ID: 10476252
[No Abstract] [Full Text] [Related]
14. [Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
Sculier JP; Paesmans M; Bureau G; Dabouis G; Libert P; Vandermoten G; Van Cutsem O; Berchier MC; Ries F; Michel J
Rev Mal Respir; 1994; 11(3):257-61. PubMed ID: 8041988
[TBL] [Abstract][Full Text] [Related]
15. [Potentiation of the cytotoxic effects of anticancer drugs on human genitourinary neoplastic cells by recombinant gamma-interferon].
Yamamoto S; Tanaka H; Namba M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):699-705. PubMed ID: 3103539
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy (CAV) and surgical resection as combined modality in the therapy of small-cell lung cancer.
Gatzemeier U; Radenbach D
Panminerva Med; 1986; 28(2):63-6. PubMed ID: 3022223
[No Abstract] [Full Text] [Related]
17. [Multidisciplinary treatment for small cell lung cancer].
Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Takahashi K; Sasaki Y; Seki S
Gan To Kagaku Ryoho; 1984 Mar; 11(3):474-9. PubMed ID: 6322700
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of lung cancer--state of the art in 2000].
Nakanishi Y; Inoue K; Hara N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of lung cancer].
Dement'eva NP
Sov Med; 1984; (11):55-61. PubMed ID: 6084308
[No Abstract] [Full Text] [Related]
20. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Ettinger DS
Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
